| Charles Lamont Linyard Iii, SAC-IT | |
|
2814 S 108th St, West Allis, WI 53227-3224 | |
| (414) 885-3525 | |
| (262) 643-4617 |
| Full Name | Charles Lamont Linyard Iii |
|---|---|
| Gender | Male |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | 2814 S 108th St, West Allis, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528734357 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | 18744-130 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Charles Lamont Linyard Iii, SAC-IT 2814 S 108th St, West Allis, WI 53227-3224 Ph: (414) 885-3525 | Charles Lamont Linyard Iii, SAC-IT 2814 S 108th St, West Allis, WI 53227-3224 Ph: (414) 885-3525 |
News Archive
Sanofi-aventis announced today that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for Jevtana® (cabazitaxel) Injection in combination with prednisone for the treatment of patients with metastatic hormone-refractory prostate cancer (mHRPC) previously treated with a docetaxel-containing treatment regimen.
During the current pandemic, we've all been advised to protect ourselves from infection by the SARS-CoV-2 virus that causes COVID-19 by masking, physical distancing and frequent hand-washing.
Ten years after a transplant, a cornea from a 71-year-old donor is likely to remain as healthy as a cornea from a donor half that age, and corneas from donors over 71 perform slightly less well but still remain healthy for most transplant recipients, according to a study funded by the National Eye Institute (NEI) and led by the UC Davis Health System Eye Center and the University of Cincinnati Eye Institut
China-Biotics, Inc., a leading Chinese firm specializing in the manufacture, research, development, marketing and distribution of probiotics products, today announced its financial results for the second quarter of its 2010 fiscal year, ended September 30, 2009.
A team of UCLA bioengineers has demonstrated that its technology may go a long way toward overcoming the challenges of treatment for acute lymphoblastic leukemia, among the most common types of cancer in children, and has the potential to help doctors personalize drug doses.
› Verified 9 days ago
Nicholas Paul Hayon, Counselor Medicare: Not Enrolled in Medicare Practice Location: 10201 W Lincoln Ave, Suite 102, West Allis, WI 53227 Phone: 414-546-6880 Fax: 414-546-6891 | |
Lashawna Thomas, Counselor Medicare: Not Enrolled in Medicare Practice Location: 2814 S 108th St, West Allis, WI 53227 Phone: 414-885-3525 Fax: 262-643-4617 | |
Ashley A Mitchell, SAC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 2814 S 108th St, West Allis, WI 53227 Phone: 414-885-3525 | |
Charity Walsh, LPC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 1205 S 70th St, Ste 301, West Allis, WI 53214 Phone: 414-475-2788 | |
Mr. Christian Lamarr Lemmie, LPC, SAC-IT Counselor Medicare: Not Enrolled in Medicare Practice Location: 2424 S 102nd St, West Allis, WI 53227 Phone: 414-203-4514 | |
Nicole F Jensen, LPC Counselor Medicare: Medicare Enrolled Practice Location: 2424 S 90th St, West Allis, WI 53227 Phone: 414-773-4312 Fax: 414-329-5637 | |
Grace Ellul, Counselor Medicare: Not Enrolled in Medicare Practice Location: 10150 W National Ave Ste 390, West Allis, WI 53227 Phone: 414-545-4430 |